| __timestamp | Bio-Techne Corporation | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 55430000 |
| Thursday, January 1, 2015 | 40853000 | 65510000 |
| Friday, January 1, 2016 | 45187000 | 71160000 |
| Sunday, January 1, 2017 | 53514000 | 70644000 |
| Monday, January 1, 2018 | 55329000 | 70418000 |
| Tuesday, January 1, 2019 | 62413000 | 63238000 |
| Wednesday, January 1, 2020 | 65192000 | 59777000 |
| Friday, January 1, 2021 | 70603000 | 60152000 |
| Saturday, January 1, 2022 | 87140000 | 54540000 |
| Sunday, January 1, 2023 | 92493000 | 52243000 |
| Monday, January 1, 2024 | 96664000 | 64536000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bio-Techne Corporation and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting trends in their R&D investments.
Bio-Techne Corporation has shown a remarkable increase in its R&D budget, growing by approximately 212% from 2014 to 2024. This surge underscores the company's strategic focus on pioneering advancements in the biotech field. In contrast, Taro Pharmaceutical Industries Ltd. experienced a more modest growth of around 16% over the same period, reflecting a steadier approach to innovation.
These trends highlight the dynamic nature of the biotech industry, where companies must balance aggressive R&D investments with sustainable growth strategies. As we look to the future, the commitment to R&D will continue to shape the competitive landscape of this vital sector.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Cost of Revenue: Key Insights for Bio-Techne Corporation and Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Bio-Techne Corporation and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Amicus Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Arrowhead Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Research and Development Investment: Mesoblast Limited vs Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.